The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases. Its lead candidate is DM199, a ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

DiaMedica Therapeutics, Inc. (DMAC Quick Quote DMAC - Free Report) closed the last trading session at $5.76, gaining 26.9% over the past four weeks, but there could be plenty of upside left in the ...

DiaMedica Therapeutics, Inc. (DMAC Quick Quote DMAC - Free Report) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, DMAC's ...

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell ...

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. DiaMedica Therapeutics, Inc. (DMAC) is a stock that can certainly ...

View DiaMedica Therapeutics Inc. DMAC stock quote prices, financial information, real-time forecasts, and company news from CNN.